Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tranylcypromine in mind (Part I): Review of pharmacology
S. Ulrich, Roland Ricken, Mazda Adli
European Neuropsychopharmacology (2017) Vol. 27, Iss. 8, pp. 697-713
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Yuan Fang, Guochao Liao, Bin Yu
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 350
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths
P. Ken Gillman
Journal of Neural Transmission (2018) Vol. 125, Iss. 11, pp. 1707-1717
Closed Access | Times Cited: 242
Efficacy and Adverse Effects of Tranylcypromine and Tricyclic Antidepressants in the Treatment of Depression
S. Ulrich, Roland Ricken, Pichit Buspavanich, et al.
Journal of Clinical Psychopharmacology (2019) Vol. 40, Iss. 1, pp. 63-74
Closed Access | Times Cited: 184
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Kunal Nepali, Jing‐Ping Liou
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 143
MAO inhibitors and their wider applications: a patent review
Simone Carradori, Daniela Secci, Jacobus P. Petzer
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 3, pp. 211-226
Closed Access | Times Cited: 118
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseases
Moussa B. H. Youdim
Journal of Neural Transmission (2018) Vol. 125, Iss. 11, pp. 1719-1733
Closed Access | Times Cited: 106
Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations
Franciele Cordeiro Gabriel, Daniela Oliveira de Melo, Renério Fráguas, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0231700-e0231700
Open Access | Times Cited: 88
Antidepressant Drugs Effects on Blood Pressure
Anna Calvi, Ilaria Fischetti, Ignazio Verzicco, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 80
Clinical advances in targeting epigenetics for cancer therapy
Shengrui Feng, Daniel D. De Carvalho
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1214-1239
Open Access | Times Cited: 70
Novel Pharmacological Approaches to the Treatment of Depression
Elias Elias, Ariel Y. Zhang, Melissa T. Manners
Life (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 48
Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
Lizeth Sepúlveda-Lizcano, Vivian Vanessa Arenas-Villamizar, Enna Beatriz Jaimes-Duarte, et al.
European Journal of Investigation in Health Psychology and Education (2023) Vol. 13, Iss. 8, pp. 1505-1520
Open Access | Times Cited: 26
Drug‐Related Hypertension: A Disproportionality Analysis Leveraging the FDA Adverse Event Reporting System
Hao Zhu, Le-kun Pan, Hock Foong Lui, et al.
Journal of Clinical Hypertension (2025) Vol. 27, Iss. 3
Open Access | Times Cited: 1
Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: A systematic review and network meta-analysis
Robert Suchting, Vaishali Tirumalaraju, Rida Gareeb, et al.
Journal of Affective Disorders (2021) Vol. 282, pp. 1153-1160
Closed Access | Times Cited: 50
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
Vincent Van den Eynde, Wegdan R. Abdelmoemin, Magid M. Abraham, et al.
CNS Spectrums (2022) Vol. 28, Iss. 4, pp. 427-440
Open Access | Times Cited: 35
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
Samuel R. Chamberlain, David S. Baldwin
CNS Drugs (2021) Vol. 35, Iss. 7, pp. 703-716
Open Access | Times Cited: 36
Prescriber's Guide
Stephen M. Stahl
(2020)
Closed Access | Times Cited: 33
Repurposing antidepressants for anticancer drug discovery
Yihui Song, Xiaoke Yang, Bin Yu
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1924-1935
Closed Access | Times Cited: 31
Copper(I) Photocatalyzed Bromonitroalkylation of Olefins: Evidence for Highly Efficient Inner‐Sphere Pathways
Alexander Reichle, Magdalena Koch, Hannes Sterzel, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 16
Open Access | Times Cited: 12
Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants
X.M. Hart, Moritz Spangemacher, Julie Defert, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 2, pp. 155-169
Closed Access | Times Cited: 4
An Exploration of the Interplay Between Caffeine and Antidepressants Through the Lens of Pharmacokinetics and Pharmacodynamics
John Truong, Noor Abu-Suriya, Daniel Tory, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2025)
Open Access
Dynamics of Cell Fate Decisions during Chemically Induced Multi‐Lineage Trans‐Differentiation at Single‐Cell Level
E Weigao, Lijiang Fei, Jingjing Wang, et al.
Advanced Science (2025)
Open Access
Exploring the Addictive Potential of Tranylcypromine
Luis Filipe Torres Cruz de Lima, Laura Fernandes Berto, Victor Hugo Spitz, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Unravelling the target landscape of tranylcypromines for new drug discovery
Yihui Song, Junbiao Chang, Bin Yu
Acta Pharmaceutica Sinica B (2025)
Open Access
The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles.
Vincent Van den Eynde, P. Ken Gillman, Barry Blackwell
PubMed (2022) Vol. 52, Iss. 2, pp. 73-116
Closed Access | Times Cited: 16
Rapid proteomic analysis for solid tumors revealsLSD1 as a drug target in an end‐stage cancer patient
Sophia Doll, Maximilian C. Kriegmair, Alberto Santos, et al.
Molecular Oncology (2018) Vol. 12, Iss. 8, pp. 1296-1307
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top